Evaluation of the Child and Family Traumatic Stress Intervention
NCT ID: NCT01031615
Last Updated: 2011-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
112 participants
INTERVENTIONAL
2005-10-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Addressing Traumatic Stress Symptoms in Children
NCT03334942
Early Intervention After Traumatic Exposure in Children and Adolescents
NCT07207018
Trauma-Focused Cognitive Behavior Therapy for Youth: Effectiveness in a Community Setting
NCT01649141
Examining the Effectiveness of an Early Psychological Intervention to Prevent Post-Traumatic Stress Disorder
NCT00895518
Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder (TreatChildTrauma)
NCT01516827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Child and Family Traumatic Stress Interv
4-session secondary prevention model that focuses on family communication about symptoms of a child aged 7-16.
Child and Family Traumatic Stress Interv (CFTSI)
4 sessions involving both the target child and a parent/caregiver
Psychoeducational Comparison
4-sessions focused on individual child using psychoeducation and relaxation skills
Psychoeducational Comparison
4 individually focused sessions including psychoeducation and relaxation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Child and Family Traumatic Stress Interv (CFTSI)
4 sessions involving both the target child and a parent/caregiver
Psychoeducational Comparison
4 individually focused sessions including psychoeducation and relaxation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Autism or Developmental Disability
* Diagnosed with psychosis or bipolar disorder
* Non-english speaking
7 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yale University School of Medicine Child Study Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Berkowitz, M.D.
Role: STUDY_DIRECTOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale University Child Study Center
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Berkowitz SJ, Stover CS, Marans SR. The Child and Family Traumatic Stress Intervention: secondary prevention for youth at risk of developing PTSD. J Child Psychol Psychiatry. 2011 Jun;52(6):676-85. doi: 10.1111/j.1469-7610.2010.02321.x. Epub 2010 Sep 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAMHSA U79SM54318
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
0504027679
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.